Blood tumor marker levels were not significantly elevated, with CEA at 5.67 (2.61, 14.48) ng/mL, NSE at 17.24 (13.21, 37.66) ng/mL, and CYFRA21‐1 at 9.19 (4.79, 16.1) ng/mL. The gene discussed is ENO2; the disease is neoplasm.